ACE2 and COVID-19: Avoiding the administration of non-steroidal anti-inflammatory drugs and targeting the ACE or angiotensin II type I receptor are advised for the treatment of COVID-19.28 Here, virtual screening indicated that dalbavancin potentially binds to ACE2 by interacting with the spike-binding region of the ACE2 protein.